首页|化学药品中的遗传毒性杂质的质量控制

化学药品中的遗传毒性杂质的质量控制

扫码查看
药品中微量水平的遗传毒性物质具有引发肿瘤甚至癌症的风险,并且该致癌风险可能与剂量没有相关性.因此,目前各国监管机构要求对药品中遗传毒性杂质进行严格控制.本综述通过查阅国内外相关文献、指导原则,从监管机构对药品中遗传毒性杂质的监管策略、遗传毒性杂质来源、检测方法及清除策略4个方面进行了系统的总结综述.该综述为药品中遗传毒性杂质的控制/清除、检测提供了参考和依据.
Quality control of genotoxicity impurities in chemicals
When the drugs contain trace levels of genotoxic substances,there is a risk of causing tumors or even cancer,and the carcinogenic risk may not be correlated to the drug dosage.Therefore,at present,regulatory authorities in various countries strictly control genotoxicity impurities in drugs.This review systematically summarized the relevant literature and guiding principles both domestically and internationally for impurities in drugs,including their regulatory strategies,sources,detection methods and elimination strategies for genotoxicity impurities in drugs.This review provides a reference and guideline for the control/elimination and detection of genotoxicity impurities in drugs.

Genotoxicity impuritySourceDetection methodClean up

田冶、陶晓莎、冯媛媛、姚尚辰、尹利辉、宁保明

展开 >

中国食品药品检定研究院,北京 102629

烟台大学,烟台 264003

遗传毒性杂质 来源 检测方法 清除

2024

中国抗生素杂志
中国医药集团总公司四川抗菌素工业研究所,中国医学科学院医药生物技术研究所

中国抗生素杂志

CSTPCD北大核心
影响因子:1.08
ISSN:1001-8689
年,卷(期):2024.49(1)
  • 17